Upload
buitu
View
219
Download
0
Embed Size (px)
Citation preview
Magnetic resonance examinations
on lipid metabolism in
insulin resistance and beyond
Chris Boesch PhD & MD
Departments of Clinical Research and Radiology
MR Spectroscopy and Methodology
University and Inselspital Bern
International Conference on Diabetes Washington D.C. July 18th – 19th, 2014
Learning Objectives
• How can Magnetic Resonance Imaging (MRI) and
Spectroscopy (MRS) elucidate lipid metabolism in vivo?
• Pertinent studies on insulin resistance and diabetes type 2
using MRI and MRS
• Future developments and limitations of MRI/MRS
for studies of lipid metabolism in vivo
Outline of the talk
• Insulin resistance => lipid vs. glucose metabolism
• Why such an emphasis on Magnetic Resonance
Imaging and (multinuclear) Spectroscopy?
• Different organs affected
• Lipid compartments, body composition, visceral fat
• Lipid composition of adipose tissue and hepatic fat
• Intra- (IMCL) vs. extramyocellular (EMCL) lipids
• Lipids in liver (IHCL), heart (ICCL), pancreas (IPCL)
• Developments and limitations of MRI/MRS
Terminology
Metabolic
syndrome
Obesity
Insulin
resistance
Diabetes
Ep
idem
iolo
gy
Path
op
hysio
log
y
an
d C
linic
s
2010
Obesity (BMI≥30 kg/m2) Diabetes
Age-Adjusted Prevalence of Obesity and Diagnosed Diabetes Among U.S. Adults
<4.5% Missing data
4.5%–5.9% 6.0%–7.4%
7.5%–8.9% ≥9.0%
18.0%–21.9%
<14.0% Missing Data
14.0%–17.9%
22.0%–25.9% ≥26.0%
http://www.cdc.gov/diabetes/statistics
Cardiovascular Risk of Metabolic Syndrome / Insulin Resistance
nwhc.net, yogiwellnessjourney.blogspot.com
Magnetic Resonance: Non invasive access to the organs
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365: 1415 (2005)
Liver Adipose
Tissue Skeletal
Muscle
Pancreas
Heart
That you may already know….
e.g. SIEMENS TIM TRIO
3.0 Tesla = 128 MHz 1H
“Contrast mechanism” in MR
Petersen (GE), Golman et al (PNAS), Basford et al. (Arch.Phys.Med.Rehabil.), Finn (Radiology), radiologie-city-plaza, SIEMENS, Uni Freiburg, AMSM Bern
1 ppm 2 3 4
MR Spectrum
4 3 2 1
e.g. Lactate
chemical shift => chemical identity
sig
nal in
tensity
=>
co
nce
ntr
atio
ns
OH
-OOC-CH-CH3
-
Multinuclear MR imaging/spectroscopy
Glucose extra Glucose intra Glucose-6-Phosphate
Transport Hexokinase
UDP-Glucose Glycogen
Glycogen-synthase
Glycogen-phosphorylase
Glycolysis
TCA-Cycle
ATP PCr Beta-oxidation IMCL, IHCL, ICCL
Glutamate (labeled)
Acetylcarnitine
Acetyl-CoA
Glucose-1-Phosphate
Pyruvate Lactate Adipose tissue
1H-MRS
1H-MRS
1H-MRS
1H-MRI
13C-MRS
13C-MRS
13C-MRS
Hyperpolarized metabolites
13C-MRS
31P-MRS
31P-MRS
31P-MRS
Phospholipid metabolism
Metabolic Syndrome / Insulin Resistance Pathophysiology, Different Organs
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365: 1415 (2005)
Functional MRI of skeletal muscle: Whole Body Assessment of Adipose Tissue Compartments during a Lifestyle Intervention
Machann J et al. Radiology 257: 353 (2010)
Insulin resistant Insulin sensitive
Insulin
resistant
Insulin
sensitive
TULIP intervention
Kantartzis K, Machann J, Schick F, et al. Effects of a lifestyle intervention in metabolically
benign and malign obesity. Diabetologia 2011;54:864-868.
OIR = Obese, insulin resistant
MHO = metabolically benign
or healthy obesity
Lipid Composition: 1H spectra
Machann J, Stefan N, Schabel C, Schleicher E, Fritsche A,
Wurslin C, Haring HU, Claussen CD, Schick F (2013) Fraction of
unsaturated fatty acids in visceral adipose tissue (VAT) is lower
in subjects with high total VAT volume - a combined 1 H MRS
and volumetric MRI study in male subjects. NMR Biomed 26:
232-236.
Lipid composition: Visceral adipose tissue
Machann J, Stefan N, Schabel C, Schleicher E, Fritsche A, Wurslin C, Haring HU, Claussen CD, Schick F (2013)
Fraction of unsaturated fatty acids in visceral adipose tissue (VAT) is lower in subjects with high total VAT volume
- a combined 1 H MRS and volumetric MRI study in male subjects. NMR Biomed 26: 232-236.
Lipid composition: 13C spectra Effects of diet
Hwang JH, Bluml S, Leaf A, Ross BD. In vivo characterization of fatty acids in human adipose tissue using natural
abundance 1H decoupled 13C MRS at 1.5 T: clinical applications to dietary therapy. NMR Biomed. 2003; 16: 160-167.
(1) -CH=CH- or
-CH=CH-CH2-CH=CH-
(2) -CH=CH-CH2-CH=CH-
Lipid composition of neonates: Development with age
Thomas EL, Hanrahan JD, Ala-Korpela M, Jenkinson G,
Azzopardi D, Iles RA, Bell JD. Noninvasive characterization
of neonatal adipose tissue by 13C magnetic resonance
spectroscopy. Lipids 1997; 32: 645-651.
Lipid composition of membranes: Hepatic phospholipid metabolism
Schlemmer HP, Sawatzki T, Sammet S, Dornacher I, Bachert P, van Kaick G, Waldherr R, Seitz HK. Hepatic phospholipids in
alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy. J.Hepatol. 2005; 42: 752-759.
55y, female, fibrosis 49y, male, cirrhosis
Metabolic Syndrome / Insulin Resistance Pathophysiology, Different Organs
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365: 1415 (2005)
Fat-selective MRI of skeletal muscle: Spectral-spatial-selective pulses and correlation with metabolic data
Machann J, Bachmann OP, Brechtel K, et al. J Magn Reson Imaging 2003;17:350-357.
32y, male, IS 34y, male, IR
27y, male, IR 34y, female, IS
TA m.tibialis anterior
TP m.tibialis posterior
GL m.gastrocnemius lateralis
GM m.gastrocnemius medialis
SOL m.soleus
PLB m.peroneus longus et brevis
1H MR spectrum of skeletal muscle
Arbitrary vertical scales
ppm 7 4 2 ppm 78 3 ppm 8
Deoxy-
myoglobin Carnosine
Creatine
TMA
Taurine
IMCL
EMCL
Acetyl-
Carnitine
Lactate
Two types of lipids: Schick et al. Magn.Reson.Med. 29: 158-167 (1993)
soleus muscle yellow bone marrow
Origin of the two lipid compartments: Rotation of skeletal muscle in the magnetic field B0
Boesch, Slotboom, Hoppeler, Kreis.
Magn.Reson.Med. 37: 484 (1997)
M. tibialis anterior
32 yr old woman
PRESS, 20ms TE
Myocellular lipids:
EMCL (extra) is
affected by orientation,
IMCL (intra) is not
Cr-CH2
Cr-CH3
EMCL CH2
IMCL CH2
4 3 2 1 0 ppm
[degrees]
-16
0
31
52
68
80
Adipose tissue vs. intramyocellular lipids [EMCL vs. IMCL]
subcutaneous fat
muscular fasciae
Intramyocellular
Lipids = IMCL
Extramyocellular
Lipids = EMCL
EMCL vs. IMCL signals with varying adipose tissue
C.Boesch & R.Kreis.
Ann.NY Acad.Sci.
904: 25-31 (2000)
EMCL
IMCL
10 % 0.1 %
subcutaneous fat
muscular fasciae
muscle tissue
1 %
0.0 2.0 4.0 6.0 8.0 10.0 12.0
0.0
1.0
2.0
3.0
4.0
5.0
6.0
0.0 2.0 4.0 6.0 8.0 10.0 12.0
0.0
1.0
2.0
3.0
4.0
5.0
6.0
0.0 2.0 4.0 6.0 8.0 10.0 0.0
2.0
4.0
6.0
8.0
10.0
12.0
12.0
Morphometry: Vv (lit, f) [mmol/kg ww] Biochemistry: triglycerides [mmol/kg ww]
Vv (
lit, f)
[m
mo
l/kg
ww
]
MR
S: IM
CL [m
mo
l/kg
ww
]
Howald, Boesch, Kreis et al.
J.Appl.Physiol. 92: 2264 (2002)
trained
untrained
r = 0.934
r = 0.475
r = 0.413
MR
S: IM
CL [m
mo
l/kg
ww
]
Biochemistry: triglycerides [mmol/kg ww]
Same subject examined 48 h and
1 week after exhaustive exercise
Comparison MRS, biochemical analysis and morphometry
Comparison MRS, biochemical analysis and morphometry
Howald, Boesch, Kreis et al. J.Appl.Physiol. 92: 2264 (2002)
Correlation coefficient r
Slope Intercept
[mmol/kg ww]
1H-MRS vs.
EM morphometry 0.934
0.467 ± 0.059 p < 0.001
0.367 ± 0.305 n.s.
1H-MRS vs.
biochemical assay 0.413
0.196 ± 0.153 n.s.
1.414 ± 0.859 n.s.
EM morphometry vs.
biochemical assay 0.475
0.445 ± 0.292 n.s.
2.352 ±1.639 n.s.
Lipoproteins and phospholipids
http://www.uwsp.edu/
EM MRS
1H-MRS: Diffusion in IMCL Droplets
Fujimoto T et al. Histochem Cell Biol 130: 263. 2008
Classical view Hypothesis
Lipid droplets
in Leukocytes
1H-MRS: Diffusion in IMCL Droplets M
ag
neti
c f
ield
gra
die
nt
Free Restricted or Hindered
0.611.52ppm
b = 6.0x103
s/mm2
0.611.52ppm
b = 1.4x104
s/mm2
0.611.52ppm
b = 2.4x104
s/mm2
0.611.52ppm
b = 3.8x104
s/mm2
0.611.52ppm
b = 5.4x104
s/mm2
EMCL vs. IMCL: Decay due to diffusion
IMCL
EMCL
IMCL IMCL IMCL
IMCL
EMCL
EMCL
EMCL
EMCL
Brandejsky V, Kreis R, Boesch C. Restricted or severely hindered diffusion of intramyocellular lipids in
human skeletal muscle shown by in vivo proton MR spectroscopy. Magn Reson Med 2012;67:310-316.
Depletion and replenishment of intramyocellular lipids
IMCL
4 4 4 3 3 3 2 2 2 1 1 1 ppm ppm ppm
Susceptibility
1H-MRS: Intramyocellular Lipids (IMCL) Other Influences: Exercise and Diet
low lipid diet
(6 % fat)
0.0
4.0
2.0
6.0
8.0
0 1 2 3 4 5
high lipid diet
(63 % fat)
[days post marathon]
M.vastus medialis M.vastus intermedius M.tibialis anterior
0 1 2 3 4 5 0.0
4.0
8.0 diet
12.0
[mm
ol/kg w
w]
[mm
ol/kg w
w]
work
Boesch C, Decombaz J, Slotboom J, Kreis R. Proc Nutr Soc 1999;58:841-850.
1H-MRS: Intramyocellular Lipids (IMCL) Relation with Insulin Sensitivity
Stein, Szczepaniak,
Dobbins, Snell, McGarry.
ISMRM Annual Meeting
(1998), p.388 (abstract)
Krssak, Petersen,
Dresner, DiPietro, Vogel,
Rothman, Shulman,
Roden. Diabetologia
42:113-116 (1999)
Jacob, Machann, Rett,
Brechtel, Volk, Renn, Maerker,
Matthaei, Schick, Claussen,
Häring.
Diabetes 48: 1113-1119 (1999)
Obese diabetes patients
show higher IMCL levels
(TML = Total muscle lipids)
Higher IMCL related to lower
insulin sensitivity
Higher IMCL levels in insulin
resistant patients
Stein et al. ISMRM Abstract 1998
Krssak et al. Diabetologia 1999
Jacob et al. Diabetes 1999
1H-MRS: Intramyocellular Lipids (IMCL) Relation with Insulin Sensitivity
1/HOMA: Insulin sensitive >>>
0
1
2
3
4
5
6
0 1 2
Resting IMCL [mmol/kg ww]
endurance runners
sedentary subjects
Decombaz, Schmitt, Ith, Decarli, Diem, Kreis, Hoppeler, Boesch. Am.J.Physiol. 281: R760 (2001)
HOMA = homeostasis model assessment
= (fasting GLU x fasting INS) / 22.5
1/HOMA : T>UT p<0.05 1H-MRS in tibialis ant m.
1H-MRS: Intramyocellular Lipids (IMCL) Relation with Insulin Sensitivity
Three-dimensional relationship between VO2max, IMCL in tibialis anterior muscle
and insulin sensitivity.
Thamer, Machann,
Bachmann, Haap, Dahl,
Wietek, Tschritter, Niess,
Brechtel, Fritsche,
Claussen, Jacob, Schick,
Haring, Stumvoll. J Clin
Endocrinol Metab 2003,
88:1785-1791.
IR
IS
low high
IS
high
IR
high
Intramyocellular lipids (IMCL) Cause or consequence?
Petersen KF, Shulman GI.
Etiology of insulin resistance.
Am.J.Med. 2006; 119: S10-S16.
Thamer, Machann, Bachmann, Haap, Dahl,
Wietek, Tschritter, Niess, Brechtel, Fritsche,
Claussen, Jacob, Schick, Haring, Stumvoll.
J Clin Endocrinol Metab 2003, 88:1785-1791.
1H-MRS: Intramyocellular Lipids (IMCL) Relation with Insulin Sensitivity
Insulin resistant Sedentary Athletes
Intr
am
yocellu
lar
lipid
s (
IMC
L)
“Bad” IMCL? “Good” IMCL?
Intramyocellular lipids (IMCL) Cause or consequence?
Ith M, Zwygart K, Stettler R, Le KA, Christ E, Schmid JP, Kreis R, Vermathen P, Boesch C.
Proc.Intl.Soc.Magn.Reson.Med. 2007; 15: 2604.
m.quadriceps femoris
Effect of fructose overconsumption in offspring T2D and controls
Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L (2009) Am J Clin Nutr 89: 1760-1765.
Vegan diet: IMCL and HOMA
Goff LM, Bell JD, So PW, Dornhorst A, Frost GS (2005)
Veganism and its relationship with insulin resistance and intramyocellular lipid. Eur J Clin Nutr 59: 291-298.
<= Insulin Sensitivity
<= Beta Cell Activity
IMCL: Influence of 2 Weeks Training
IMCL content, expressed as percentage of the water resonance. White bars, before cycling
test; black bars, after cycling test. *, Significant differences.
“The Increase in Intramyocellular Lipid Content Is a Very Early Response to Training”
Schrauwen-Hinderling,
Schrauwen, Hesselink,
van Engelshoven,
Nicolay, Saris, Kessels,
Kooi.
J Clin Endocrinol Metab
2003, 88:1610-1616.
1H-MRS: Intramyocellular Lipids (IMCL) Influence of free fatty acids
Examples of 1H-spectra of one subject at different time points for TA during
hyperinsulinemia + lipid infusion (a), and during hyperinsulinemia alone (c).
Brechtel, Dahl, Machann, Bachmann, Wenzel, Maier, Claussen, Haring, Jacob, Schick.
Magn Reson Med 2001, 45:179-183
13C-MRS: Glycogen depletion and recovery
ppm 150 100
Creatine Glycogen
Rest
6 h
2 h
30 min
recovery
& nutrition
1.5 h 70 % VO2max in intervals
Rotman S, Slotboom J, Kreis R, Boesch C, Jequier E.
Magn Reson Mater Phy 2000;11:114-121.
IMCL and Glycogen: Influence of hyperglycemia
S.Jenni, C.Oetliker,
S.Allemann, M.Ith, L.Tappy,
S.Wuerth, A.Egger, C.Boesch,
Ph.Schneiter, P.Diem,
E.Christ, C.Stettler,
Diabetologia 2008, 51, 1457
IMCL and Glycogen: Influence of hyperglycemia Substrate selection by the body
S.Jenni, C.Oetliker, S.Allemann, M.Ith, L.Tappy, S.Wuerth, A.Egger, C.Boesch,
Ph.Schneiter, P.Diem, E.Christ, C.Stettler, Diabetologia 2008, 51, 1457
Percent
Euglycaemia
Hyperglycaemia
0 20 40 60 80 100 Proteins
Lipids
Endogenous
glucose
Glucose
infusion
Glycogen
1H-MRS 13C-MRS
1H-MRS: Acetylcarnitine
ppm 1.0 2.0 3.0 4.0 5.0
> Exercise leads to:
— Utilization of IMCL
(1) Kreis R et al., NMR Biomed 1999; 12:471.
— Production of
acetylcarnitine (AcCar1)
IMCL
TMA
AcCar
N +
O
COO -
O
TMA
AG - AcCar
N +
O
COO -
O
TMA
-
Acetylcarnitine after heavy workload
0 0
2
3
1
5 20 25 30 time [min]
work- load
Metabolites
Acetylcarnitine
S [au]
Acetylcarnitine as marker for Acetyl-CoA from increased fat oxidation?
-1
0
1
2
3
4
5
6
∆ A
cety
lcarn
itin
e [a
.u.]
Euglycemia Hyperglycemia
p < 0.01 B
Boss A, Kreis R, Jenni S, Ith M, Nuoffer JM, Christ E, Boesch C, Stettler C, Diabetes Care 2011; 34:220.
Acetylcarnitine
Acetyl-CoA ~103
1H-MRS: Acetylcarnitine
> Car: involved in transport of fatty acids into mitochondria
> Car: buffers excess acetyl-CoA by producing AcCar
From Carlin JI et al., J Appl Physiol 1990;69:42.
Muscle biopsies
Acetylcarnitine
Acetyl-CoA ~103
Acetylcarnitine
Lindeboom L, Nabuurs C, Hoeks J, Vosselman M, Brouwers B,
van de Weijer T, Timmers S, Phielix E, Kooi E, Hesselink M,
Wildberger J, Schrauwen P, Schrauwen-Hinderling V. Resting
acetylcarnitine concentration in skeletal muscle, as measured
with long TE 1H-MRS, is associated with insulin sensitivity.
Proc.Intl.Soc.Magn.Reson.Med. 2014; 22: 3604.
How is the excess acetyl-CoA produced?
Mitochondrion
TCA
cycle
Acetyl-CoA
Harris RC et al., J Appl Physiol 1987; 63:440. Spriet LL et al., Am J Physiol 1992; 263:C653.
Pyruvate
Glycogen Glucose /
CARBOHYDRATE OXIDATION
PDC
FAT OXIDATION
Free fatty acids / IMCL
CPT-I
Acetylcarnitine
Acetylcarnitine Carnitine
Carnitine
Cytoplasm
13C-MRS: Mitochondrial Activity, TCA cycle
-> [2-13C] acetate infusion
-> 13C incorporation into glutamate C4 (33.6 - 35.0 ppm)
-> modeling (Cwave software) -> TCA cycle flux
Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline
GW, Shulman GI. Science 2003; 300: 1140-1142.
PYR
AcCoA
OAA
CIT
a-Keto-
glutarate
TCA-
cycle
Glutamate C4
[2-13C] Acetate
Metabolic Syndrome / Insulin Resistance Pathophysiology, Different Organs
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365: 1415 (2005)
MRS vs. Imaging based methods
Kim H, Taksali SE, Dufour S, Befroy D,
Goodman TR, Petersen KF, Shulman
GI, Caprio S, Constable RT.
Comparative MR study of hepatic fat
quantification using single-voxel proton
spectroscopy, two-point dixon and three-
point IDEAL.
Magn.Reson.Med. 2008; 59: 521-527.
Effects of a short-term overfeeding with
fructose or glucose in healthy young males
Eleven subjects, 7 days diet:
(1) weight maintenance, control diet
(2) High Fructose Diet (3·5 g
fructose/kg fat-free mass per day)
(3) High Glucose Diet (3·5 g
glucose/kg fat free mass per day)
muscle
liv
er
Ngo Sock ET, Le KA, Ith M, Kreis R,
Boesch C, Tappy L. Effects of a short-
term overfeeding with fructose or glucose
in healthy young males. Br J Nutr 103:
939-943 (2010).
Effect of fructose overconsumption in offspring T2D and controls
Le KA, Ith M, Kreis R, Faeh D, Bortolotti M, Tran C, Boesch C, Tappy L (2009) Am J Clin Nutr 89: 1760-1765.
Effect of exercise: Average DIMCL/IMCLpre and DIHCL/IHCLpre
DIMCL DIHCL+/- SEM +/- SEM
-40%
-30%
-20%
-10%
0%
10%
20%
30%
40%
50%
Skeletal
muscle:
IMCL
p = 0.006
Liver:
IHCL
p = 0.026
Effect of exercise on IMCL and IHCL
Adipose
tissue
Liver
Working
muscle
Glycogen
Glucose
FFA
IHCL FFA
IMCL
Lipid Composition: Liver vs. subcutaneous/visceral fat
Lundbom J, Hakkarainen A,
Soderlund S, Westerbacka J,
Lundbom N, Taskinen MR
(2011) Long-TE 1H MRS
suggests that liver fat is more
saturated than subcutaneous
and visceral fat. NMR Biomed
24: 238-245.
Metabolic Syndrome / Insulin Resistance Pathophysiology, Different Organs
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365: 1415 (2005)
Intracardiomyocellular lipids: ICCL
Ith M, Stettler C, Xu J, Boesch C,
Kreis R. Cardiac lipids show diurnal
changes and long-term variations in
healthy human subjects. NMR
Biomed. 2014; minor revision.
Intracardiomyocellular lipids: ICCL Diurnal changes and long-term variations
Ith M, Stettler C, Xu
J, Boesch C, Kreis
R.
Cardiac lipids show
diurnal changes and
long-term variations
in healthy human
subjects.
NMR Biomed. 2014;
minor revision.
IMCL, IHCL, ICCL: Effects of exercise
Bucher J, Kruesi M, Zueger T, Ith M, Stettler C, Diem P, Boesch C, Kreis R, Christ E. The effect of a single bout of a 2h
aerobic exercise on ectopic lipids in skeletal muscle, liver and the myocardium. Diabetologia 2014; 57: 1001-1005.
ICCL cardio
IHCL hepato
IMCL myo
Myocardial fat in metabolic syndrome
Nyman K, Graner M, Pentikainen MO, Lundbom J, Hakkarainen A, Siren R, Nieminen MS, Taskinen MR, Lundbom N, Lauerma
K (2013) Cardiac steatosis and left ventricular function in men with metabolic syndrome. J Cardiovasc Magn Reson 15: 103.
Cardiac Steatosis in DM2 Dallas Heart Study
McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R, Levine BD, Raskin P, Victor RG, Szczepaniak LS.
Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study.
Circulation 2007; 116: 1170-1175.
Myocardial fat in dilated cardiomyopathy
Graner M, Pentikainen MO, Nyman K, Siren R, Lundbom J,
Hakkarainen A, Lauerma K, Lundbom N, Nieminen MS, Petzold
M, Taskinen MR (2014) Cardiac steatosis in patients with dilated
cardiomyopathy. Heart [doi: heartjnl-2013-304961]
Myocardial triglyceride Epicardial fat Pericardial fat
(TG) content
Metabolic Syndrome / Insulin Resistance Pathophysiology, Different Organs
Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 365: 1415 (2005)
Pancreatic fat: Multiecho
Thomas EL, Fitzpatrick JA, Malik SJ,
Taylor-Robinson SD, Bell JD.
Whole body fat: Content and
distribution.
Prog.NMR Spectroscopy 2013; 73:
56-80.
Pancreatic fat – measured by MRS
Lingvay I, Esser V, Legendre JL, et al.
Noninvasive quantification of pancreatic fat in humans.
J Clin Endocrinol Metab 2009;94:4070-4076.
Pancreatic fat – Fat selective imaging
Heni M, Machann J, Staiger H, Schwenzer NF,
Peter A, Schick F, Claussen CD, Stefan N,
Haring HU, Fritsche A.
Pancreatic fat is negatively associated with
insulin secretion in individuals with impaired
fasting glucose and/or impaired glucose
tolerance: a nuclear magnetic resonance study.
Diabetes Metab.Res.Rev. 2010; 26: 200-205.
Pancreatic fat: MRS vs. IDEAL
Hu HH, Kim HW, Nayak KS, Goran
MI. Comparison of fat-water MRI and
single-voxel MRS in the assessment
of hepatic and pancreatic fat
fractions in humans. Obesity 2010;
18: 841-847.
Summary and Outlook
> Advantages / disadvantages
> Development
> Methodological competitors
Magnetic resonance imaging and (multinuclear) spectroscopy vs. other methods
> PRO‘s > Non invasive Biopsy
> Non ionizing PET, CT
> Repeatable External tracers, biopsy
> Localized Body fluids, breathing air
> CON‘s > Insensitive PET, PET/CT, PET/MR etc.
> Not beside, not mobile US, blood sample, etc
> Expenses, availability US, blood sample, etc
MRI and MRS: Future developments
> Stronger magnetic fields (7 Tesla, 9.4 Tesla, …)
— Increased sensitivity (signal-to-noise-ratio)
— Better spectral resolution (MR spectroscopy)
— Increased effects (e.g. signals of brain activation)
> New acquisition techniques (e.g. coil arrays, sampling scheme)
— Faster acquisition
— Increased sensitivity
> Hyperpolarized substances
— Increased sensitivity
— Better spatial resolution (Metabolite images)
> Availability
— Neurosciences (fact)
— Physiology, sports medicine, endocrinology (wishful thinking?)
Advantages of ultra-high magnetic fields Examples at 7 Tesla
Wijsman CA, van Opstal AM, Kan HE,
Maier AB, Westendorp RG, Slagboom PE,
Webb AG, Mooijaart SP, van Heemst D.
Proton magnetic resonance spectroscopy
shows lower intramyocellular lipid
accumulation in middle-aged subjects
predisposed to familial longevity.
Am.J.Physiol. 2012; 302: E344-E348.
Ren J, Dimitrov I, Sherry AD, Malloy CR.
Composition of adipose tissue and marrow fat in
humans by 1H NMR at 7 Tesla. J.Lipid Res.
2008; 49: 2055-2062.
4 3 2 1 ppm
13C-MRS: Hyperpolarized substances [13C1]-pyruvate metabolism in human prostate cancer
Nelson SJ, Kurhanewicz J, Vigneron DB, Larson
PE, Harzstark AL, Ferrone M, Van CM, Chang
JW, Bok R, Park I, Reed G, Carvajal L, Small EJ,
Munster P, Weinberg VK, rdenkjaer-Larsen JH,
Chen AP, Hurd RE, Odegardstuen LI, Robb FJ,
Tropp J, Murray JA.
Metabolic imaging of patients with prostate cancer
using hyperpolarized [1-13C]-pyruvate.
Sci.Transl.Med. 2013; 5: 198ra108.
Images of lactate/pyruvate
indicate cancer
Studies of metabolism in
insulin resistance limited by
time restrictions of
hyperpolarization -
nonetheless enormous
potential
Take home message
• Insulin resistance: prominent application of multinuclear MRI/MRS
• MR is non-invasive, non-ionizing, localized, and repeatable
• Multiple organs accessible
• Insulin resistance involves lipid and carbohydrate metabolism
• Body composition, fat compartments
• Lipid composition
• IMCL, IHCL, ICCL, IPCL
• Further development, stronger magnetic fields, techniques
• Availability for physiologists, endocrinologists, sports medicine, etc.
Thank you….